Streetbeat News

Products Services

EADSY

Cathay Pacific has identified 15 Airbus A350 planes needing engine part replacements after an inspection following an engine component failure on a flight. The airline has already repaired three of the affected planes and expects all to be operational by Saturday. The issue led to the cancellation of 34 flights, but other airlines with similar planes have not been instructed to inspect their fleets.

Portfolio Pulse from Anan Ashraf

September 03, 2024 | 11:19 am

RDHL

Redhill Biopharma published data from a Phase 2/3 study of Opaganib in COVID-19 pneumonia, showing a 62% reduction in mortality and a 21% improvement in time to room air. The study suggests FiO2 levels as a potential biomarker for disease severity.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 11:14 am

PCVX

Vaxcyte announced positive results from its Phase 1/2 study of VAX-31, a 31-valent pneumococcal conjugate vaccine candidate. The vaccine showed strong immune responses and a good safety profile, meeting regulatory criteria. Vaxcyte plans to advance to Phase 3 trials for adults and initiate a Phase 2 study for infants.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 11:12 am

UNCY

Unicycive Therapeutics has submitted a New Drug Application to the FDA for Oxylanthanum Carbonate, targeting hyperphosphatemia in chronic kidney disease patients on dialysis. The company is seeking approval through the 505(B)(2) regulatory pathway.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 11:06 am

RNAC

Cartesian Therapeutics has initiated a Phase 1 trial for Descartes-15, an mRNA-engineered CAR T-cell therapy targeting multiple myeloma. The trial will evaluate safety and tolerability, with future plans to explore autoimmune applications.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 11:04 am

AUUD

AUUDW

Auddia Inc. has integrated Apple CarPlay and Android Auto into its faidr app, enhancing in-car listening experiences. This move aligns with the growing trend of smartphone mirroring in vehicles, which is a significant factor for car buyers.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 10:59 am

HAP

PWER

SHEL

Shell plc (NYSE:SHEL) shares are trading lower premarket after announcing a 10-year LNG supply agreement with Turkey's BOTAŞ. The deal will supply up to 4 billion cubic meters of LNG annually starting in 2027, aiding Turkey's gas diversification. Shell aims to expand its LNG capacity by 20-30% by 2030. Shell shares have gained 16% over the past year, and investors can access the stock via ETFs like Macquarie Energy Transition ETF (NYSE:PWER) and VanEck Natural Resources ETF (NYSE:HAP).

Portfolio Pulse from Lekha Gupta

September 03, 2024 | 10:53 am

MRK

The European Commission has approved Merck's Keytruda in combination with Padcev for the first-line treatment of unresectable or metastatic urothelial carcinoma in adults.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 10:49 am

MSFT

NVDA

The article discusses the impact of AI on jobs, highlighting Alorica's use of AI translation tools to boost productivity without cutting jobs. Prominent tech leaders like Bill Gates, Elon Musk, and Sam Altman have varying views on AI's role in the workforce. Companies like Microsoft and Nvidia are advancing AI technologies, with Nvidia providing full-stack AI solutions.

Portfolio Pulse from Benzinga Neuro

September 03, 2024 | 10:43 am

KALV

KalVista Pharmaceuticals' NDA for sebetralstat, an oral treatment for hereditary angioedema, has been accepted by the FDA. If approved, it could become the first oral on-demand treatment for HAE by mid-2025.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 10:32 am